Ciudad de la Habana, Cuba

Julio R Maso


Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julio R Maso: Innovator in Genetic Engineering

Introduction

Julio R Maso is a prominent inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of genetic engineering, particularly in the study of pathogenic Neisseria strains. His work focuses on the isolation and identification of nucleotide sequences that are crucial for developing diagnostic methods and vaccines.

Latest Patents

Julio R Maso holds a patent for a nucleotide sequence coding for an outer membrane protein from Neisseria. This invention involves a method for isolating a nucleotide sequence that codes for a protein with a molecular weight of approximately 64,000 daltons, located on the outer membrane of Neisseria meningitidis. The recombinant DNA obtained from this sequence is utilized for transforming host microorganisms. The primary goal of this invention is to identify a nucleotide sequence coding for a highly conserved protein found in most pathogenic Neisseria strains. This protein can be produced in high purity and commercially useful amounts, making it valuable for diagnostic methods and vaccine preparations with broad immunoprotection.

Career Highlights

Julio R Maso is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to advance research in genetic engineering and biotechnology. His work has been instrumental in enhancing the understanding of Neisseria and its implications for public health.

Collaborations

Some of his notable coworkers include Silva Rodriquez and Selman H Sosa, who have collaborated with him on various research projects.

Conclusion

Julio R Maso's innovative work in genetic engineering has the potential to significantly impact the fields of diagnostics and vaccine development. His contributions are vital for advancing our understanding of pathogenic Neisseria strains and improving public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…